References
[1] Schutt E.G., Klein D.H., Mattrey R.M., Riess J.G. (2003):
“Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals”.
Angew Chem Int Ed 42:3218-3235.
[2] Hoff L. (2001): “Acoustic characterization of contrast agents for medical ultrasound imaging”. Kluwer Academic Publishers, Dordrecht.
[3] de Jong N. (1993): “Acoustic properties of ultrasound contrast agents”. Ph.D. thesis, Erasmus University, Rotterdam, The Netherlands.
[4] Kono Y., Steinbach G.C., Peterson T., Schmid-Schöenbein G.W., Mattrey R.F. (2002): “Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: an intravital microscopy study in rats”.
Radiology 224:253-257.
[5] Gramiak R., Shah P.M. (1968): “Echocardiography of the aortic root”. Invest. Radiol. 3:356-366.
[6] Gramiak R., Shah P.M., Kramer D.H. (1969): “Ultrasound cardiography: contrast studies in anatomy and function”.
Radiology 92:939-948.
[7] Meltzer R.S., Roelandt J. (1982): “Contrast echocardiography”. Martinus Nijhoff Publishers, The Hague/Boston/London.
[8] Tickner G., Rasor N. (1977): “Noninvasive assessment of pulmonary hypertension using the bubble ultrasonic resonance
pressure (Burp) method”. Annual report # HR-62917-1A, NHLBI.
[9] Bommer W.J., Neef J., Neumann A., Weinert L, Lee G, Mason T, Demaria AN (1978): “Indicator dilution curves obtained by photometric analysis of two-dimensional echo-contrast studies”. Am. J. Cardiol. 41:370.
[10] Tei C., Sakamaki T., Shah P.M., Meerbaum S., Shimoura K., Kondo S., Corday E. (1983): “Myocardial contrast echocardiography: a reproducible technique of myocardial opacification for identifying regional perfusion deficits”.
Circulation 67:585-593.
[11] Feinstein S.B., Ten Cate F.J., Zwehl W., Ong K., Maurer G., Tei C., Shah P.M., Meerbaum S., Corday E. (1984): “Two- dimensional contrast echocardiography, I: in vivo development and quantitative analysis of echo contrast agents”. J. Am. Coll.
Cardiol 3:14-20.
[12] Ten Cate F.J., Feinstein S.B., Zwehl W., Meerbaum S., Fishbein M., Shah P.M., Corday E. (1984): “Two-dimensional contrast echocardiography, II: transpulmonary studies”. J. Am.
Coll. Cardiol. 3:21-27.
[13] Ong K., Maurer G., Feinstein S.B., Zwehl W., Meerbaum S., Corday E. (1984): “Computer methods for myocardial contrast two-dimensional echocardiography”. J. Am. Coll. Cardiol.
3:1212-1218.
[14] von Bibra H, Hartmann F, Petrik M, Schlief R, Renner U, Blomer H (1989): “Contrast-color Doppler echocardiography.
Improved right heart diagnosis following intravenous injection of Echovist”. Z Kardiol 78:101-108.
[15] Feinstein S.B., Cheirif J., Ten Cate F.J., Silverman P.R., Heidenreich P.A., Dick C., Desir R.M., Armstrong W.F., Quinones M.A., Shah P.M. (1990): “Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results”. J. Am. Coll. Cardiol. 16:316-324.
[16] Goldberg B.B., Liu J-B., Burns P.N., Merton D.A., Forsberg F.
(1993): “Galactose-based intravenous sonographic contrast agent: experimental studies”. J. Ultrasound. Med. 12:463-470.
[17] Schurmann R., Schlief R. (1994): “Saccharide-based contrast agents. Characteristics and diagnostic potential”. Radiol. Med.
87(5 Suppl 1):15-23.
[18] Kaul S., Senior R., Dittrich H., Raval U., Khattar R., Lahiri A.
(1997): “Detection of coronary artery disease with myocardial contrast echocardiography: comparison with 99mTc-sestamibi single-photon emission computed tomography”. Circulation 96:785-792.
[19] Burns P.N., Wilson S.R., Simpson D.H. (2000): “Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast”. Invest.
Radiol. 35:58-71.
[20] Dittrich H.C., Bales G.L., Kuvelas T., Hunt R.M., McFerran B.A., Greener Y. (1995): “Myocardial contrast echocardiography in experimental coronary artery occlusion with a new intravenously administered contrast agent”. J. Am.
Soc. Echocardiogr. 8:465-474.
[21] Hancock J., Dittrich H., Levitt D.E., Monaghan M.J. (1999):
“Evaluation of myocardial, hepatic, and renal perfusion in a variety of clinical conditions using an intravenous ultrasound contrast agent (Optison) and second harmonic imaging”. Heart 81:636-641.
[22] Cwajg J., Xie F., O’Leary E., Kricsfeld D., Dittrich H., Porter T.R. (2000): “Detection of angiographically significant coronary artery disease with accelerated intermittent imaging after intravenous administration of ultrasound contrast material”. Am. Heart. J. 139:675-683.
[23] Cohen J.L., Cheirif J., Segar D.S., Gillam L.D., Gottdiener J.S., Hausnerova E., Bruns D.E. (1998): “Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial”. J. Am. Coll.
Cardiol. 32:746-752.
[24] Shaw L.J., Gillam L., Feinstein S., Dent J., Plotnick G. (1998):
“Use of an intravenous contrast agent (Optison) to enhance echocardiography: efficacy and cost implications. Optison
Multicenter Study Group”. Am. J. Managed Care 4:SP169- 176.
[25] Skyba D.M., Kaul S. (2000): “Advances in microbubble technology”. Coronary Artery Disease 11:211-219.
[26] Kabalnov A., Klein D., Pelura T., Schutt E., Weers J. (1998):
“Dissolution of multicomponent microbubbles in the bloodstream: 1. Theory”. Ultrasound. Med. Biol. 24:739-749.
[27] Kabalnov A., Bradley J., Flaim S., Klein D., Pelura T., Peters B., Otto S., Reynolds J., Schutt E., Weers J. (1998):
“Dissolution of multicomponent microbubbles in the bloodstream: 2. Experiment”. Ultrasound. Med. Biol. 24:751- 760.
[28] Wei K., Kaul S. (1997): “Recent advances in myocardial contrast echocardiography”. Curr. Opin. Cardiol. 12:539-546.
[29] Lindner J.R., Firschke C., Wei K., Goodman N.C., Skyba D.M., Kaul S. (1998): “Myocardial perfusion characteristics and hemodynamic profile of MRX-115, a venous echocardiographic contrast agent, during acute myocardial infarction”. J. Am. Soc. Echocardiogr. 11:36-46.
[30] Wei K., Firoozan S., Ates G., Linka A., Goodman N.C., Kaul S. (1997): “Quantification of the severity of coronary stenoses using venous injections of minute amounts of AFO150 during intermittent harmonic imaging”. J Am. Coll. Cardiol. 29:292A.
[31] Schneider M., Arditi M., Barrau M., Brochot J., Broillet A., Ventrone R., Yan F. (1995): “BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles”. Invest. Radiol. 30:451-457.
[32] Skyba D.M., Camarano G., Goodman N.C., Price R.J., Skalak T.C., Kaul S. (1996): “Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second generation contrast agent capable of producing myocardial opacification from a venous injection”. J. Am. Coll.
Cardiol. 28:1292-1300.
[33] Porter T.R., Xie F., Knapp D., Iversen P., Marky L.A., Tsutsui J.M., Maiti S., Lof J., Radio S.J., Kipshidze N. (2006):
“Targeted vascular delivery of antisense molecules using intravenous microbubbles”. Cardiovasc. Revasc. Med. 7:25-33.
[34] Yoshida J., Ohmori K., Takeuchi H., Shinomiya K., Namba T., Kondo I., Kiyomoto H., Kohno M. (2005): “Treatment of ischemic limbs based on local recruitment of vascular endothelial growth factor-producing inflammatory cells with ultrasonic microbubble destruction”. J. Am. Coll. Cardiol.
46:899-905.
[35] Straub J.A., Chickering D.E., Church C.C., Shah B., Hanlon T., Bernstein H. (2005): “Porous PLGA microparticles: AI- 700, an intravenously administered ultrasound contrast agent for use in echocardiography”. J. Control Release 108:21-32.
[36] Thomsen H.S., Muller R., Mattrey R.F. (1999): “Medical radiology – Diagnostic imaging and radiation oncology series”. Springer, Heidelberg.
[37] Mulvagh S.L., Demaria A.N., Feinstein S.B., Burns P.N., Kaul S., Miller J.G., Monaghan M., Porter T.R., Shaw L.J., Villanueva F.S. (2000): “Contrast echocardiography: current and future applications”. J. Am. Soc. Echocardiogr. 13:331- 342.
[38] Becher H., Burns P.N. (2000): “Handbook of contrast echocardiography”. Springer, Berlin.
[39] Goldberg B.B., Raichlen J.S., Forsberg F. (2001): “Ultrasound contrast agents – Basic principles and clinical applications”.
Martin Dunitz, London.
[40] Nanda N.C., Kitzman D.W., Dittrich H.C., Hall G., Imagent Clinical Investigators Group (2003): “Imagent improves endocardial border delineation, inter-reader agreement, and the accuracy of segmental wall motion assessment”.
Echocardiography 20:151-161.
[41] Coley B.D., Trambert M.A., Mattrey R.F. (1994):
“Perfluorocarbon-enhanced sonography: value in detecting acute venous thrombosis in rabbits”. Am. J. Roentgenol.
163:961-964.
[42] Sirlin C.B., Lee Y.Z., Girard M.S., Peterson T.M., Steinbach G.C., Baker K.G., Mattrey R.F. (2001): “Contrast-enhanced B- mode US angiography in the assessment of experimental in vivo and in vitro atherosclerotic disease”. Acad. Radiol. 8:162- 172.
[43] Kono Y., Pinnell S.P., Sirlin C.B., Sparks S.R., Georgy B., Wong W., Mattrey R.F. (2004): “Carotid arteries: contrast- enhanced US angiography--preliminary clinical experience”.
Radiology 230:561-568.
[44] Girard M.S., Mattrey R.F., Baker K.G., Peterson T., Deiranieh L.H., Steinbach G.C. (2000): “Comparison of standard and second harmonic B-mode sonography in the detection of segmental renal infarction with sonographic contrast in a rabbit model”. J. Ultrasound Med. 19:185-192.
[45] Wilson S.R., Burns P.N. (2001): “Liver mass evaluation with ultrasound: the impact of microbubble contrast agents and pulse inversion imaging”. Semin Liver Dis. 21:147-159.
[46] Strohmeyer D., Frauscher F., Klauser A., Recheis W., Eibl G., Horninger W., Steiner H., Volgger H., Bartsch G. (2001):
“Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer”.
Anticancer Res. 21:2907-2913.
[47] Halpern E.J., Verkh L., Forsberg F., Gomella L.G., Mattrey R.F., Goldberg B.B. (2000): “Initial experience with contrast- enhanced sonography of the prostate”. Am. J. Roentgenol 174:1575-1580.
[48] Girard M.S., Kono Y., Sirlin C.B., Baker K.G., Deiranieh L.H., Mattrey R.F. (2001): “B-mode enhancement of the liver with microbubble contrast agent: a blinded study in rabbits with VX2 tumors”. Acad. Radiol. 8:734-740.
[49] Taylor G.A., Barnewolt C.E., Adler B.H., Dunning P.S.
(1998): “Renal cortical ischemia in rabbits revealed by contrast-enhanced power Doppler sonography”. Am. J.
Roentgenol 170:417-422.
[50] Blomley M.J.K., Cooke J.C., Unger E.C., Monaghan M.J., Cosgrove D.O. (2001): “Microbubble contrast agents: a new era in ultrasound”. Br. Med. J. 322:1222-1225.
[51] Albrecht T., Hoffmann C.W., Schmitz S.A., Schettler S., Overberg A., Germer C.T., Wolf K.J. (2001): “Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases”. Am. J.
Roentgenol 176:1191-1198.
[52] Bartels E., Bittermann H.J. (2006): “Transcranial contrast imaging of cerebral perfusion in patients with space-occupying intracranial lesions”. J. Ultrasound. Med. 25:499-507.
[53] Lanza G.M., Wickline S.A. (2001): “Targeted ultrasonic contrast agents for molecular imaging and therapy”. Prog.
Cardiovasc. Dis. 44:13-31.
[54] Schumann P.A., Christiansen J.P., Quigley R.M., McCreery T.P., Schweitzer R.H., Unger E.C., Lindner J.R., Matsunaga T.O. (2002): “Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi”. Invest. Radiol.
37:587-593.
[55] Lindner J.R., Song J., Christiansen J., Klibanov A.L., Xu F., Ley K. (2001): “Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin”.
Circulation 104:2107-2112.
[56] Ferrara K.W., Merritt C.R., Burns P.N., Foster F.S., Mattrey R.F., Wickline S.A. (2000): “Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents”. Acad.
Radiol. 7:824-839.
[57] Porter T.R., LeVeen R.F., Fox R., Kricsfeld A., Xie F. (1996):
“Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles”. Am. Heart J.
132:964-968.
[58] Birnbaum Y., Luo H., Nagai T., Fishbein M.C., Peterson T.M., Li S., Kricsfeld D., Porter T.R., Siegel R.J. (1998):
“Noninvasive in vivo clot dissolution without a thrombolytic drug: recanalization of thrombosed iliofemoral arteries by
transcutaneous ultrasound combined with intravenous infusion of microbubbles”. Circulation 97:130-134.
[59] Frinking P.J.A., de Jong N. (1998): “Acoustic modelling of shell-encapsulated gas bubbles”. Ultrasound Med. Biol.
24:523-533.
[60] Shi W.T., Forsberg F., Hall A.L., Chiao R.Y., Liu J.B., Miller S., Thomenius K.E., Wheatley M.A., Goldberg B.B. (1999):
“Subharmonic imaging with microbubble contrast agents:
Initial results”. Ultrason Imaging 21:79-94.
[61] Hoff L., Sontum P.C., Hovem J.M. (2000): “Oscillations of polymeric microbubbles: Effect of the encapsulating shell”. J.
Acoust. Soc. Am. 107:2272-2280.
[62] Morgan K.E., Allen J.S., Dayton P.A., Chomas J.E., Klibanov A.L., Ferrara K.W. (2000): “Experimental and theoretical evaluation of microbubble behaviour: Effect of transmitted phase and bubble size”. IEEE Trans Ultrason Ferroelectr Freq Control 47:1494-1509.
[63] de Jong N., Hoff L. (1993): “Ultrasound scattering properties of Albunex microspheres”. Ultrasonics 31:175-181.
[64] Gorce J-M., Arditi M., Schneider M. (2000): “Influence of bubble size distribution on the echogenicity of ultrasound contrast agents: A study of Sonovue™”. Invest. Radiol.
35:661-671.
[65] Reinhardt M., Hauff P., Briel A., Uhlendorf V., Linker R.A., Maurer M., Schirner M. (2005): “Sensitive particle acoustic quantification (SPAQ): a new ultrasound-based approach for the quantification of ultrasound contrast media in high concentrations”. Invest. Radiol. 40:2-7.
[66] de Jong N., Bouakaz A., Ten Cate F.J. (2002): “Contrast harmonic imaging”. Ultrasonics 40:567-573.
[67] Shi W.T., Forsberg F. (2000): “Ultrasonic characterization of nonlinear properties of contrast microbubbles”. Ultrasound Med. Biol. 26:93-104.
[68] Krishna P.D., Newhouse V.L. (1997): “Second harmonic characteristics of the ultrasound contrast agents Albunex and FS069”. Ultrasound Med. Biol. 23:453-459.
[69] Kvikliene A., Jurkonis R., Ressner M., Hoff L., Jansson T., Janerot-Sjoberg B. Lukosevicius A., Ask P. (2004):
“Modelling of nonlinear effects and the response of ultrasound contrast microbubbles: simulation and experiment”.
Ultrasonics 42:301-307.
[70] Bouakaz A., Versluis M., de Jong N. (2005): “High-speed optical observations of contrast agent destruction”. Ultrasound Med. Biol. 31:391-399.
[71] Chen Q., Zagzebski J., Wilson T., Stiles T. (2002): “Pressure- dependent attenuation in ultrasound contrast agents”.
Ultrasound Med. Biol. 28:1041-1051.
[72] Tang M-X., Eckersley R.J., Noble A. (2005): “Pressure- dependent attenuation with microbubbles at low mechanical index”. Ultrasound Med. Biol. 31:377-384.
[73] Wu J., Pepe J., Dewitt W. (2003): “Nonlinear behaviors of contrast agents relevant to diagnostic and therapeutic applications”. Ultrasound Med. Biol. 29:555-562.
[74] Kruse D.E., Ferrara K.W. (2005): “A new imaging strategy using wideband transient response of ultrasound contrast agents”. IEEE Trans. Ultrason. Ferroelectr. Freq. Control.
52:1320-1329.
[75] Sun Y., Kruse D.E., Dayton P.A., Ferrara K.W. (2005): “High- frequency dynamics of ultrasound contrast agents”. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 52:1981-1991.
[76] Goertz D.E., Frijlink M.E., Tempel D., van Damme L.C., Krams R., Schaar J.A., Ten Cate F.J., Serruys P.W., de Jong N., van der Steen A.F. (2006): “Contrast harmonic intravascular ultrasound: a feasibility study for vasa vasorum imaging”. Invest. Radiol. 41:631-638.
[77] Miller A.P., Nanda N.C. (2004): “Contrast echocardiography:
new agents”. Ultrasound Med. Biol. 30:425-434.
[78] Bertolotto M., Pozzato G., Croce L.S., Nascimben F., Gasparini C., Cova M.A., Tiribelli C. (2006): “Blood flow changes in hepatocellular carcinoma after the administration of thalidomide assessed by reperfusion kinetics during microbubble infusion: preliminary results”. Invest. Radiol.
41:15-21.
[79] Broumas A.R., Pollard R.E., Bloch S.H., Wisner E.R., Griffey S., Ferrara K.W. (2005): “Contrast-enhanced computed tomography and ultrasound for the evaluation of tumor blood flow”. Invest. Radiol. 40:134-147.
[80] Unger E.C., Matsunaga T.O., McCreery T., Schumann P., Sweitzer R., Quigley R. (2002): “Therapeutic applications of microbubbles”. Eur. J. Rad. 42:160-168.
[81] Unger E.C., Porter T., Culp W., Labell R., Matsunaga T., Zutshi R. (2004): “Therapeutic applications of lipid-coated microbubbles”. Adv. Drug. Del. Rev. 56:1291-1314.
[82] Kondo I., Ohmori K., Oshita A., Takeuchi H., Fuke S., Shinomiya K., Noma T., Namba T., Kohno M. (2004):
“Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a “functional” gene using ultrasonic microbubble destruction”. JACC 44(3):644-653.
[83] Klibanov A.L. (2006): “Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications”. Invest. Radiol. 41:354-362.
[84] Hedrick W.R., Hykes D.L., Starchman D.E. (1995):
“Ultrasound physics and instrumentation” (Third edition).
Mosby, St. Louis.
[85] Wells P.N.T. (1977): “Biomedical Ultrasonics”. Academic Press, New York.
[86] Dowling A.P., Williams J.E.F. (1983): “Sound and sources of sound”. John Wiley and Sons, New York.
[87] D’hooge J. (1999): “Interaction of ultrasonic waves and tissues: modeling, simulations and applications”. Ph.D. thesis, Leuven University Press, Leuven, Belgium.
[88] American Institute of Ultrasound in Medicine and National Electrical Manufacturers Association: “Standard for real-time display of thermal and mechanical indices on diagnostic ultrasound equipment”. Rockville MD, 1992, AIUM-NEMA.
[89] Kremkau F.W. (2002): “Diagnostic ultrasound: principles and instruments” (Sixth edition). W.B. Saunders Company, Philadelphia.
[90] Bronzino J.D. (2000): “The biomedical engineering handbook”
(second edition). CRC Press, Boca Raton.
[91] Stergiopoulos S. (2001): “Advanced signal processing handbook”. CRC Press, Boca Raton.
[92] Trucco A., Bertora F. (2003): “Harmonic beamforming: a new approach to remove the linear contributions in harmonic imaging”. Proceedings of the 2003 IEEE International Ultrasonics Symposium 1:457-460.
[93] Ledoux L.A.F. (1999): “A modelled approach to absolute velocity detection with ultrasound”. Ph.D. thesis, Maastricht University, Maastricht, The Netherlands.
[94] Hoffmeister B.K., Verdonk E.D., Wickline S.A., Miller J.G.
(1994): “Effect of collagen on the anisotropy of quasi- longitudinal mode ultrasonic velocity in fibrous soft tissues: a comparison of fixed tendon and fixed myocardium”. J. Acoust.
Soc. Am. 96(4):1957-1964.
[95] Deng C.X., Lizzi F.L. (2002): “A review of physical phenomena associated with ultrasonic contrast agents and illustrative clinical applications”. Ultrasound Med. Biol.
28(3):277-286.
[96] Medwin H. (1977): “Counting bubbles acoustically: a review”.
Ultrasonics 15(1):7-13.
[97] Frinking P.J.A., Bouakaz A., Kirkhorn J., Ten Cate F.J., de Jong N. (2000): “Ultrasound contrast imaging: current and new potential methods”. Ultrasound Med. Biol. 26(6):965-975.
[98] de Jong N., Cornet R., Lancee C.T. (1994): “Higher harmonics of vibrating gas filled microspheres. Part one: Simulations”.
Ultrasonics 32:447-453.
[99] Hamilton M.F., Blackstock D.T. (1998): “Nonlinear acoustics”. Academic Press, San Diego.
[100] Frinking P.J.A, de Jong N., Cespedes E.I. (1999): “Scattering properties of encapsulated gas bubbles at high ultrasound pressures”. J. Acoust. Soc. Am. 105(3):1989-1996.
[101] Devin C. (1959): “Survey of thermal, radiation and viscous damping of pulsating air bubbles in water”. J. Acoust. Soc. Am.
31:1654-1667.
[102] Epstein P., Plesset M. (1950): “On the stability of gas bubbles in liquid-gas solutions”. J. Chem. Phys. 18:1505-1509.
[103] Fox F., Herzfield K. (1954): “Gas bubbles with organic skin as cavitation nuclei”. J. Acoust. Soc. Am. 26:984-989.
[104] Leighton T.G. (1994): “The acoustic bubble” (first edition).
Academic Press Ltd., London.
[105] Miller D. (1981): “Ultrasonic detection of resonant cavitation bubbles in a flow tube by their second harmonic emissions”.
Ultrasonics 22:217-224.
[106] Minnaert M. (1933): “On musical air-bubbles and the sounds of running water”. Philos. Mag. 16:235-248.
[107] Newhouse V., Shankar P. (1984): “Bubble size measurements using the nonlinear mixing of two frequencies”. J. Acoust. Soc.
Am. 75:1473-1477.
[108] Prosperetti A. (1984): “Bubble phenomena in sound fields:
part one”. Ultrasonics 22:69-77.
[109] Prosperetti A. (1984): “Bubble phenomena in sound fields:
part two”. Ultrasonics 22:115-124.
[110] Rayleigh L. (1917): “On the pressure developed in a liquid during the collapse of a spherical cavity”. Philos. Mag. 34:94- 98.
[111] Anderson A.L., Hampton L.D. (1980): “Acoustics of gas- bearing sediments. I. Background”. J. Acous. Soc. Am.
67:1865-1889.
[112] Eatock B.C., Nishi R.Y., Johnston G.W. (1985): “Numerical studies of the spectrum of low-intensity ultrasound scattered by bubbles”. J. Acoust. Soc. Am. 77:1672-1701.
[113] Morse P.M., Ingard K.U. (1968): “Theoretical acoustics”.
McGraw-Hill, New York.
[114] Ophir J., Parker K.J. (1989): “Contrast agents in diagnostic ultrasound”. Ultrasound Med. Biol. 15(4):319-333.
[115] Church C.C. (1995): “The effects of an elastic solid surface layer on the radial pulsations of gas bubbles”. J. Acoust. Soc.
Am. 97:1510-1521.
[116] Zhen Y. (1996): “On sound scattering and attenuation of Albunex bubbles”. J. Acoust. Soc. Am. 100:2011-2028.
[117] Young R.F. (1989): “Cavitation”. McGraw-Hill, Oxford.
[118] de Jong N., Hoff L., Skotland T., Bom N. (1992): “Absorption and scatter of encapsulated gas-filled microspheres: theoretical considerations and some measurements”. Ultrasonics 30:95- 103.
[119] Uhlendorf V. (1994): “Physics of ultrasound contrast imaging:
scattering in the linear range”. IEEE Trans. Ultrason.
Ferroelectr. Freq. Contr. 41:70-79.
[120] Kaul S., Jayaweera R. (1997): “Coronary and myocardial blood volumes. Noninvasive tools to assess the coronary microcirculation”. Circulation 96:719-724.
[121] Bouakaz A., Frinking P., de Jong N. (1999): “Ultrasound imaging based on nonlinear pressure field properties”. 15th International Symposium on Nonlinear Acoustics, Gottingen, Germany.
[122] Powers J.E., Burns P.N., Soquet J. (1997): “Imaging instrumentation for ultrasound contrast agents. Advances in echo imaging using contrast enhancement”. In: Nanda N.,
Schlief R., Goldberg B., eds. Dordrecht, The Netherlands:
Kluwer Academic: 139-170.
[123] Simpson D.H., Chin C.T., Burns P.N. (1999): “Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents”. IEEE Trans. Ultrason.
Ferroelectr. Freq. Contr. 46(2):372-382.
[124] Simpson D.H., Burns P.N. (1998): “Perfusion imaging with pulse inversion Doppler and microbubble contrast agents: in vivo studies of the myocardium”. 1998 IEEE Ultrasonics Symposium Proceedings: 1783-1786.
[125] Porter T.R., Xie F. (1995): “Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles. Demonstration and potential mechanisms”. Circulation 92:2391-2395.
[126] Kamiyama N., Moriyasu F., Mine Y., Goto Y. (1999):
“Analysis of flash echo from contrast agent from designing optimal ultrasound diagnostic systems”. Ultrasound Med. Biol.
25(3):411-420.
[127] Frinking P.J.A., Cespedes E.I., Kirkhorn J., Torp H.G., de Jong N. (2001): “A new ultrasound contrast imaging approach based on the combination of multiple imaging pulses and a separate release burst”. IEEE Trans. Ultrason. Ferroelectr. Freq.
Contr. 48:643-651.
[128] Skyba D.M., Price R.J., Linka A.Z., Skalak T.C., Kaul S.
(1998): “Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissues”. Circulation 98:290-293.
[129] Wei K., Skyba D.M., Firschke C., Jayaweera A.R., Lindner J.R., Kaul S. (1997): “Interactions between microbubbles and ultrasound: in vitro and in vivo observations”. J. Am. Coll.
Cardiol. 29:1081-1088.
[130] Walker K.W., Pantely G.A., Sahn D.J. (1997): “Ultrasound- mediated destruction of contrast agents: effects of ultrasound intensity, exposure and frequency”. Invest. Radiol. 32:728-734.
[131] Frinking P.J.A., Cespedes E.I., de Jong N. (1998): “Multi- pulse ultrasound contrast imaging based on a decorrelation detection strategy”. 1998 IEEE Ultrasonics Symposium Proceedings: 1787-1790.
[132] Shankar P.M., Krishna P.D., Newhouse V.L. (1998):
“Advantages of subharmonic over second harmonic backscatter for contrast-to-tissue echo enhancement”.
Ultrasound Med. Biol. 24(3):395-399.
[133] Browne J.E., Ramnarine K.V., Watson A.J., Hoskins P.R.
(2003): “Assessment of the acoustic properties of common tissue-mimicking test phantoms”. Ultrasound Med. Biol.
29(7):1053-1060.
[134] Claassen L., Seidel G., Algermissen C. (2001): “Quantification of flow rates using harmonic grey-scale imaging and an ultrasound contrast agent: an in vitro and in vivo study”.
Ultrasound Med. Biol. 27(1):83-88.
[135] Leischik R., Rose J., Caspari G., Skyschally A., Heusch G., Erbel R. (1997): “Contrast echocardiography for assessment of myocardial perfusion”. Herz 22(1):40-50.
[136] Monaghan M.J., Metcalfe J.M., Odunlami S., Waaler A., Jewitt D.E. (1993): “Digital radiofrequency echocardiography in the detection of myocardial contrast following intravenous administration of Albunex”. Eur. Heart J. 14(9):1200-1209.
[137] Wilson B., Shung K.K., Hete B., Levene H., Barnhart J.L.
(1993): “A feasibility study on quantitating myocardial perfusion with Albunex, an ultrasonic contrast agent”.
Ultrasound Med. Biol. 19(3):181-191.
[138] Bouakaz A., Frigstad S., Ten Cate F.J., de Jong N. (2002):
“Improved contrast to tissue ratio at higher harmonics”.
Ultrasound Med. Biol. 40(1-8):575-578.
[139] Burns P.N. (1996): “Harmonic imaging with ultrasound contrast agents”. Clin. Radiol. 51(Suppl. 1):50-55.
[140] Chang P.H., Shung K.K., Wu S., Levene H.B. (1995): “Second harmonic imaging and harmonic Doppler measurements with
Albunex”. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 42(6):1020-1027.
[141] Schrope B., Newhouse V.L., Uhlendorf V. (1992): “Simulated capillary blood flow measurement using a nonlinear ultrasonic contrast agent”. Ultrason. Imaging 14(2):134-158.
[142] Verbeek X.A.A.M., Willigers J.M., Brands P.J., Ledoux L.A.F., Hoeks A.P.G. (1999): “Measurement of the contrast agent intrinsic and native harmonic response with single transducer pulse waved ultrasound systems”. Ann. Biomed.
Eng. 27(5):670-681.
[143] Bruce M., Averkiou M., Tiemann K., Lohmaier S., Powers J., Beach K. (2004): “Vascular flow and perfusion imaging with ultrasound contrast agents”. Ultrasound Med. Biol. 30(6):735- 743.
[144] Zheng W., Newhouse V.L. (1998): “Onset delay of acoustic second harmonic backscatter from bubbles or microspheres”.
Ultrasound Med. Biol. 24(4):513-522.
[145] Filipczynski L., Wojcik J., Kujawska T., Lypacewicz G., Tymkiewicz R., Zienkiewicz B. (2001): “Nonlinear native propagation effects of diagnostic ultrasound computed and measured in blood”. Ultrasound Med. Biol. 27(2):251-257.
[146] Sannino A., Esposito A., Nicolais L., Del Nobile M.A., Giovane A., Balestrieri C., Esposito R., Agresti M. (2000):
“Cellulose-based hydrogels as body water retainers”. J. Mater.
Sci. Mater. Med. 11(4):247-253.
[147] Ward M., Wu J., Chiu J.F. (2000): “Experimental study of the effects of Optison concentration on sonoporation in vitro”.
Ultrasound Med. Biol. 26:1169-1175.
[148] Porter T.R., Oberdorfer J., Rafter P., Lof J., Xie F. (2003):
“Microbubble responses to a similar mechanical index with different real-time perfusion imaging techniques“. Ultrasound Med. Biol. 29:1187-1192.
[149] Sboros V., Moran C.M., Anderson T., Pye S.D., Macleod I.C., Millar A.M., McDicken W.N. (2000): “Evaluation of an
experimental system for the in vitro assessment of ultrasonic contrast agents”. Ultrasound Med. Biol. 26:105-111.
[150] Sboros V., Moran C.M., Anderson T., Gatzoulis L., Criton A., Averkiou M., Pye S.D., McDicken W.N. (2001): “An in vitro system for the study of ultrasound contrast agents using a commercial imaging system”. Phys. Med. Biol. 46:3301-3321.
[151] Harris C.M. (1991): “Handbook of acoustical measurements and noise control”. Acoustical Society of America, Melville, NY.
[152] Scabia M., Biagi E., Masotti L. (2002): “Hardware and software platform for real-time processing and visualization of echographic radiofrequency signals”. IEEE Trans. Ultrason.
Ferroelectr. Freq. Control 49:1444-1452.
[153] Burns P.N. (2002): “Instrumentation for contrast echocardiography”. Echocardiography 19:241-258.
[154] Tiemann K., Veltmann C., Ghanem A., Lohmaier S., Bruce M., Kuntz-Hehner S., Pohl C., Ehlgen A., Schlosser T., Omran H., Becher H. (2001): “The impact of emission power on the destruction of echo contrast agents and on the origin of tissue harmonic signals using power pulse-inversion imaging”.
Ultrasound Med. Biol. 27:1525-1533.
[155] Becher H., Tiemann K., Schlosser T., Pohl C., Nanda N.C., Averkiou M.A., Powers J., Luderitz B. (1998): “Improvement of endocardial border delineation using tissue harmonic imaging”. Echocardiography 15:511-517.
[156] Thomas J.D., Rubin D.N. (1998): “Tissue harmonic imaging:
why does it work?”. J. Am. Soc. Echocardiogr. 11:803-808.
[157] Chen W.S., Brayman A.A., Matula T.J., Crum L.A. (2003):
“Inertial cavitation dose and hemolysis produced in vitro with or without Optison”. Ultrasound Med. Biol. 29:725-737.
[158] Bailey M.R., Blackstock D.T., Cleveland R.O., Crum L.A.
(1999): “Comparison of electrohydraulic lithotripters with rigid and pressure-release ellipsoidal reflectors. II. Cavitation fields”. J. Acoust. Soc. Am. 106:1149-1160.
[159] Coleman A.J., Saunders J.E., Crum L.A., Dyson M. (1987):
“Acoustic cavitation generated by an extracorporeal shockwave lithotripter”. Ultrasound Med. Biol. 13:69-76.
[160] Crum L.A. (1988): “Cavitation microjets as a contributory mechanism for renal calculi disintegration in ESWL”. J. Urol.
140:1587-1590.
[161] Sokolov D.L., Bailey M.R., Crum L.A. (2001): “Use of dual- pulse lithotripter to generate a localized and intensified cavitation field”. J. Acoust. Soc. Am. 110:1685-1695.
[162] AIUM (American Institute of Ultrasound in Medicine) (2000):
“Mechanical bioeffects from diagnostic ultrasound: AIUM consensus statements. Section 6 – Mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents”. J.
Ultrasound Med. 19:120-142.
[163] Greis C. (2004): “Technology overview: Sonovue (Bracco, Milan)”. Eur. Radiol. Suppl. 14(Suppl 8):11-15.
[164] Kindberg G.M., Tolleshaug H., Roos N., Skotland T. (2003):
“Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres”. Cell. Tissue Res. 312(1):49-54.
[165] Welch P. (1967): “The use of Fast Fourier Transform for the estimation of power spectra: a method based on time averaging over short, modified periodgrams”. IEEE Trans. Audio Electroacoust. AU-15:70-73.
[166] Chatterjee D., Sarkar K., Jain P., Schreppler N.E. (2005): “On the suitability of broadband attenuation measurement for characterizing contrast microbubbles”. Ultrasound Med. Biol.
31:781-786.
[167] Chatterjee D., Jain P., Sarkar K. (2005): “Ultrasound-mediated destruction of contrast microbubbles used for medical imaging and drug delivery”. Phys. Fluids 17:100603.
[168] Klibanov A.L., Hughes M.S., Wojdyla J.K., Wible J.H. Jr, Brandenburger G.H. (2002): “Destruction of contrast agent microbubbles in the ultrasound field: the fate of the
microbubble shell and the importance of the bubble gas content”. Acad. Radiol. 9:S41-S45.
[169] Chomas J.E., Dayton P., Allen J., Morgan K., Ferrara K.W.
(2001): “Mechanisms of contrast agent destruction”. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 48:232-248.
[170] Moran C.M., Anderson T., Pye S.D., Sboros V., McDicken W.N. (2000): “Quantification of microbubble destruction of three fluorocarbon-filled ultrasonic contrast agents”.
Ultrasound Med. Biol. 26:629-639.
[171] Chen W.S., Matula T.J., Brayman A.A., Crum L.A. (2003): “A comparison of the fragmentation thresholds and inertial cavitation doses of different ultrasound contrast agents”. J.
Acoust. Soc. Am. 113:643-651.
List of publications
Journal papers
• Casciaro S., Demitri C., Conversano F., Casciaro E., Distante A.
(2007): “Experimental investigation and theoretical modelling of the nonlinear acoustical behaviour of a liver tissue and comparison with a tissue mimicking hydrogel”. Accepted for publication in Journal of Materials Science: Materials in Medicine.
• Casciaro S., Palmizio Errico R., Conversano F., Demitri C., Distante A. (2007): “Experimental investigations of nonlinearities and destruction mechanisms of an experimental phospholipid-based ultrasound contrast agent”. Investigative Radiology 42(2):95-104.
Papers in International Conference Proceedings
• Conversano F., Casciaro S., Palmizio Errico R., Casciaro E., Distante A. (2005): “Optimizing experimental setup in simulated organs for ultrasound systems”. Proceedings of the International Federation for Medical and Biological Engineering 11(1):908- 912.
• Palmizio Errico R., Casciaro S., Conversano F., Palma G., Distante A. (2005): “Lower power ultrasound approach feasibility varying microbubble concentration”. Proceedings of the International Federation for Medical and Biological Engineering 11(1):904-907.
• Casciaro S., Palmizio Errico R., Conversano F., Demitri C., Casciaro E., Distante A. (2005): “Subharmonic imaging implementation by varying microbubble concentration”.
Proceedings of the International Federation for Medical and Biological Engineering 11(1):899-903.
• Casciaro S., Demitri C., Palmizio Errico R., Conversano F., Palma G., Casciaro E., Distante A. (2005): “Ultrasound harmonic behaviour of artificial tissues”. Proceedings of the 2005 IEEE International Ultrasonics Symposium, pp. 1668-1671.
• Palmizio Errico R., Casciaro S., Demitri C., Conversano F., Palma G., Casciaro E., Distante A. (2005): “Low microbubble concentrations signal enhancement varying echograph electrical power”. Proceedings of the 2005 IEEE International Ultrasonics Symposium, pp. 2011-2013.
• Casciaro S., Palmizio Errico R., Conversano F., Casciaro E., Ostuni L., Distante A. (2005): “Characterization methodology for sound absorption of synthetic materials in ultrasound in vitro studies”. Proceedings of the International Federation for Medical and Biological Engineering 9:315-316.
• Conversano F., Casciaro S., Palmizio Errico R., Casciaro E., Demitri C., Distante A. (2005): “Cut-off mechanical index for effective contrast imaging”. Proceedings of the International Federation for Medical and Biological Engineering 9:311-312.
• Palmizio Errico R., Casciaro S., Conversano F., Casciaro E., Palma G., Distante A. (2005): “Frequency effects on ecocontrast agents signal behaviour at low mechanical indices”. Proceedings of the International Federation for Medical and Biological Engineering 9:111-112.
• Casciaro S., Palmizio Errico R., Conversano F., Maffezzoli A., Sannino A., Distante A. (2005): “Ultrasound signal enhancement varying microbubble concentration at very low mechanical indices”. Proceedings of the International Federation for Medical and Biological Engineering 9:109-110.
Other International Conference Communications
• Casciaro S., Conversano F., Palmizio Errico R., Distante A.
(2007): “Microbubble deterioration mechanisms of a phospholipidic contrast agent”. The 12th European Symposium on Ultrasound Contrast Imaging, 25-26 January 2007, Rotterdam, The Netherlands – Selected as a finalist for the Best Technical Poster Competition.
• Casciaro S., Conversano F., Demitri C., Palmizio Errico R., Palma G., Casciaro E., Zacà D., Distante A. (2005): “Simulating animal targeted tissue acoustic behaviour to enable contrast
agent development and study”. Euroecho 9, 7-10 December 2005, Florence, Italy.
• Palmizio Errico R., Casciaro S., Demitri C., Conversano F., Palma G., Casciaro E., Bianco R., Distante A. (2005): “How power settings influence signal enhancement varying dilutions of experimental phospholipidic contrast agent”. Euroecho 9, 7-10 December 2005, Florence, Italy.
• Conversano F., Casciaro S., Palmizio Errico R., Casciaro E., Demitri C., Distante A. (2005): “Acoustic pressure thresholding for improving contrast enhancement”. 20th Advances in Contrast Ultrasound Conference, 27-28 October 2005, Chicago, IL, USA - First Prize Poster Context Winner.
• Casciaro S., Demitri C., Palmizio Errico R., Conversano F., Palma G., Casciaro E., Distante A. (2005): “Harmonic Emission in tissue-mimicking phantom”. 20th Advances in Contrast Ultrasound Conference, 27-28 October 2005, Chicago, IL, USA - First Prize Poster Context Winner.
• Casciaro S., Palmizio Errico R., Conversano F., Casciaro E., Ostuni L., Distante A. (2005): “Phonoabsorption modelization techniques for new targeted phantom materials”. 20th Advances in Contrast Ultrasound Conference, 27-28 October 2005, Chicago, IL, USA - First Prize Poster Context Winner.
• Palmizio Errico R., Casciaro S., Demitri C., Conversano F., Palma G., Casciaro E., Distante A. (2005): “Echocontrast enhancement at low microbubble concentrations varying mechanical index”. 20th Advances in Contrast Ultrasound Conference, 27-28 October 2005, Chicago, IL, USA - First Prize Poster Context Winner.
• Casciaro S., Palmizio Errico R., Conversano F., Demitri C. and Distante A. (2005): “Investigating frequency effect on microbubble acoustical behaviour at low mechanical indices”.
The 10th European Symposium on Ultrasound Contrast Imaging, 20-21 January 2005, Rotterdam, The Netherlands.
